Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
9.35
-0.85 (-8.33%)
At close: Sep 15, 2025, 4:00 PM EDT
9.31
-0.04 (-0.43%)
After-hours: Sep 15, 2025, 7:17 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Therapeutics
3.95M
Log In
Log In
Log In
Novel Therapeutics Growth
-74.60%
Log In
Log In
Log In